In a report released yesterday, Ann Hynes from Mizuho Securities reiterated a Buy rating on Tenet Healthcare (NYSE: THC), with a price target of $36. The company’s shares closed yesterday at $32.41.
According to TipRanks.com, Hynes is a 3-star analyst with an average return of 3.9% and a 54.9% success rate. Hynes covers the Services sector, focusing on stocks such as Encompass Health Corporation, Walgreens Boots Alliance, and Quest Diagnostics Inc.
Tenet Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $36.86, representing a 13.7% upside. In a report issued on July 23, Citigroup also maintained a Buy rating on the stock with a $44 price target.
.
See today’s analyst top recommended stocks >>
The company has a one-year high of $39.74 and a one-year low of $12.25. Currently, Tenet Healthcare has an average volume of 1.52M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tenet Healthcare Corp. engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities.
